3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Glioblastoma
40
Breast Neoplasms
23
Gliosarcoma
22
Esophageal Neoplasms
21
Prostatic Neoplasms
19
Carcinoma, Non-Small-Cell Lung
19
Pancreatic Neoplasms
15
Squamous Cell Carcinoma of Head and Neck
13
Rectal Neoplasms
13
Glioma
13
Brain Neoplasms
13
Uterine Cervical Neoplasms
12
Neoplasms
12
Lung Neoplasms
11
Head and Neck Neoplasms
11
Melanoma
10
Astrocytoma
10
Sarcoma
8
Precursor Cell Lymphoblastic Leukemia-Lymphoma
8
Central Nervous System Neoplasms
8
Stomach Neoplasms
7
Lymphoma, Follicular
6
Esophageal Squamous Cell Carcinoma
6
Endometrial Neoplasms
6
Adenocarcinoma Of Esophagus
6
Oropharyngeal Neoplasms
5
Neoplasm Metastasis
5
Lymphoma
5
Carcinoma
5
Burkitt Lymphoma
5
Interventions
human papillomavirus vaccine, L1 type 16, 18
35
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
23
Papillomavirus Vaccines
14
Data Collection
7
Blood Specimen Collection
7
Vaccines
6
Vaccines, Synthetic
5
Educational Status
5
Radiotherapy, Intensity-Modulated
4
Human Papillomavirus Recombinant Vaccine nonavalent
4
Early Intervention, Educational
4
Vaginal Smears
3
Surveys and Questionnaires
3
Polymerase Chain Reaction
3
Paclitaxel
3
Methods
3
Engerix-B
3
Colposcopy
3
Cisplatin
3
halofantrine
2
fludarabine phosphate
2
fludarabine
2
aldesleukin
2
Watchful Waiting
2
Taxes
2
Patient Navigation
2
Papanicolaou Test
2
Observation
2
Light Coagulation
2
Imiquimod
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Papillomavirus Infections
×
Radiation
×
Clear all
NCT02258659
2024-09-24
OPTIMA
University of Chicago
Phase 2
Completed
62 enrolled
13 charts